Literature DB >> 20459370

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias.

Florence Thibaut1, Flora De La Barra, Harvey Gordon, Paul Cosyns, John M W Bradford.   

Abstract

OBJECTIVES: The primary aim of these guidelines was to evaluate the role of pharmacological agents in the treatment and management of paraphilia, with a focus on the treatment of adults males. Because such treatments are not delivered in isolation, the role of specific psychosocial and psychotherapeutic interventions was also briefly covered. These guidelines are intended for use in clinical practice by clinicians who diagnose and treat patients with paraphilia. The aim of these guidelines is to improve the quality of care and to aid physicians in clinical decisions.
METHODS: The aim of these guidelines was to bring together different views on the appropriate treatment of paraphilias from experts representing different continents. To achieve this aim, an extensive literature search was conducted using the English language literature indexed on MEDLINE/PubMed (1990-2009 for SSRIs) (1969-2009 for antiandrogen treatments), supplemented by other sources, including published reviews.
RESULTS: Each treatment recommendation was evaluated and discussed with respect to the strength of evidence for its efficacy, safety, tolerability and feasibility.
CONCLUSIONS: An algorithm was proposed with six levels of treatment for different categories of paraphilias.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459370     DOI: 10.3109/15622971003671628

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  29 in total

Review 1.  [Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN].

Authors:  J L Müller; N Saimeh; P Briken; S Eucker; K Hoffmann; M Koller; T Wolf; M Dudeck; C Hartl; A-K Jakovljevic; V Klein; G Knecht; R Müller-Isberner; J Muysers; K Schiltz; D Seifert; A Simon; H Steinböck; W Stuckmann; W Weissbeck; C Wiesemann; R Zeidler
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

Review 2.  Psychological treatment of sex offenders.

Authors:  R Karl Hanson; Pamela M Yates
Journal:  Curr Psychiatry Rep       Date:  2013-03       Impact factor: 5.285

3.  Mandatory neurotechnological treatment: ethical issues.

Authors:  Farah Focquaert
Journal:  Theor Med Bioeth       Date:  2014-02

Review 4.  Juvenile Sex Offenders.

Authors:  Eileen P Ryan; Joseph M Otonichar
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

5.  Elderly Sexual Offenders.

Authors:  Brad D Booth
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

6.  [Failure of a study in forensic psychiatric hospitals : Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy].

Authors:  Peer Briken; Jürgen L Müller; Wolfgang Berner; Rolf-Hasso Bödeker; Jochen Vollmann; Christian Kasperk; Matthias Koller
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

7.  [Pedophilia: etiology, diagnostics and therapy].

Authors:  P Fromberger; K Jordan; J L Müller
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

Review 8.  The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders.

Authors:  Florence Thibaut; John M W Bradford; Peer Briken; Flora De La Barra; Frank Häßler; Paul Cosyns
Journal:  World J Biol Psychiatry       Date:  2015-11-23       Impact factor: 4.132

9.  Deep brain stimulation to reduce sexual drive.

Authors:  Johannes Fuss; Matthias K Auer; Sarah V Biedermann; Peer Briken; Werner Hacke
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

Review 10.  The Biological Treatment of Paraphilic Disorders: an Updated Review.

Authors:  Brian J Holoyda; Denise C Kellaher
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.